The largest GLP-1 study ever conducted was 2.4 million people through the U.S. Veteran's Affairs. GLP-1's like semaglutide and tirzepatide were found to reduce risk in 42 health conditions — making GLP-1's "one of the most exciting therapeutic tools in modern medicine."
Here's breakdown of the 42 health conditions found to be positively impacted
🧠 Brain & Mental Health
Alzheimer's disease
Dementia
Parkinson’s disease
The only UNCENSORED COMPOUNDED GLP-1 message board on the internet.
Hosted exclusively by Compound Providers.
FDA-accredited sourcing only.
No gray market or research peptide discussions. Thank you.
Understanding What’s Normal — and What It Really Means
Starting a GLP-1 medication like semaglutide or tirzepatide can be a turning point in your health journey — but it may come with a few physical changes that take you by surprise.
Let’s be clear: not everyone has side effects, and when they do happen, they’re usually short-lived, manageable, and often meaningful. Many of these changes are your body healing, not malfunctioning.
If you know what to expect and what it means, it becomes a lot easier to stay the course — and feel empowered.
Microdosing GLP‑1 medications (like semaglutide or tirzepatide) is gaining traction for metabolic health, disease prevention, and treating 42 other conditions, as well as weight management — in people with lower than 27 BMI.
I have partnered with a team of providers led by Dr. Brent Agin MD, a published expert in the peptide world with expertise spanning 25 years.
Body mass management
Enhance nutrient absorption / increase energy
Neuroprotective benefits